{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2F2nd-gen-trk-inhibitors-1h11YOHp","width":444,"version":"1.0","type":"rich","title":"Overcoming Acquired Resistance With Second-Generation TRK Inhibitors","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/165defb8-f7d7-44fe-a7eb-a59f2c35d334/675fd18e-7dcf-4b2f-95a5-bfd6c036e186/ntrk-podcasticon-3.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/6442df3b-3d58-4366-8718-82721ac90bad\" height=\"200\" width=\"100%\" title=\"Overcoming Acquired Resistance With Second-Generation TRK Inhibitors\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"In this podcast episode, listen to George D. Demetri, MD, and Alexander Drilon, MD, discuss emerging data on the efficacy, safety, and clinical role of second-generation TRK inhibitors that can overcome acquired resistance to currently approved TRK inhibitors."}